UK Biotechs Present Novel Technologies at BioTrinity 2017
Biotechnology Rolls on Despite Brexit Uncertainty
Avoiding Costly Errors in Bioassay Development
Developers Have a Range of Options When Optimizing Bioassays for Biologics
Screening Innovations and 3D Cell Culture Assay Developments
Showcased at ELRIG
New Tech Aids Drug Discovery
In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
For full access to this article login to GEN Select now.
Optimizing Transient Gene Expression
Applications Expected to Move Beyond Discovery and the Preclinic to Clinical Realm
- Transient gene expression represents an appealing and complementary alternative to the development of stable cell lines for the expression of bioengineered proteins, according to experts in the field. Yves Durocher, Ph.D., project leader from the National Research Council Biotechnology Research Institute in Montréal, Canada, and his colleagues optimized ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.